Burden of Chronic Kidney Disease in Asia From 1990 to 2023: A Global Burden of Disease Study 2023.

Authors

Jungwon Chun, Dohwi Yun, Juyeong Kim, Hyunjee Kim, Yesol Yim, Yoon Lee, Dongjin Yeo, Selin Woo, Dong Keon Yon

Published in

Nephrology (Carlton, Vic.). Volume 31. Issue 8. Pages e70253.

Abstract

Despite growing recognition of chronic kidney disease (CKD) as a major health threat in Asia, its subregional variations are often overlooked. This study aimed to assess the CKD burden across five Asian subregions.
This study analysed data from the Global Burden of Disease Study 2023 to estimate the burden of CKD in Asia. CKD cases were classified using International Classification of Diseases codes. Age-standardized mortality rates (ASMRs) and age-standardized disability-adjusted life-year (DALY) rates (ASDRs) per 100 000 population were estimated from 1990 to 2023 across 34 Asian countries, which were grouped into five subregions: Central, East, South, Southeast Asia and high-income Asia Pacific. Estimates were stratified by age, sex and underlying causes and reported with 95% uncertainty intervals (UIs), along with an assessment of major risk factors.
In 2023, Southeast Asia experienced the heaviest CKD burden, with the highest ASMR (24.73 [95% UI, 19.98-29.83] per 100 000 population) and ASDR (816.37 [695.11-964.14]). Females under 35 years in South and Southeast Asia had a higher DALY burden than males. In Southeast Asia, type 1 diabetes contributed significantly to CKD deaths (ASMR, 3.18 [95% UI, 2.38-4.18] per 100 000 population), whereas CKD deaths in Central Asia were primarily due to other causes (7.48 [6.51-8.49]). High fasting plasma glucose levels were the leading risk factor across most regions, except in Central Asia.
Although CKD is often considered uniform in Asia, our findings reveal distinct subregional drivers. Effective CKD control requires a shift from aggregated targets to precision- and region-specific strategies.

PMID:
42559978
Bibliographic data and abstract were imported from PubMed on 06 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.